NYSE:GRX - Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$10.33 0.00 (0.00 %)
(As of 07/20/2018 04:00 PM ET)
Previous Close$10.33
Today's Range$10.3206 - $10.38
52-Week Range$9.12 - $10.95
Volume33,610 shs
Average Volume45,842 shs
Market Capitalization$199.78 million
P/E RatioN/A
Dividend Yield5.15%
Beta0.87
There is no company description available for Gabelli Healthcare & WellnessRx Trust.

Receive GRX News and Ratings via Email

Sign-up to receive the latest news and ratings for GRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Investment Trusts/Mutual Funds
Sub-IndustryN/A
SectorMiscellaneous
SymbolNYSE:GRX
CUSIPN/A
WebN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares19,850,000
Market Cap$199.78

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund (NYSE:GRX) Frequently Asked Questions

What is Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's stock symbol?

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund trades on the New York Stock Exchange (NYSE) under the ticker symbol "GRX."

How often does Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund pay dividends? What is the dividend yield for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund?

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund announced a quarterly dividend on Friday, May 18th. Investors of record on Friday, June 15th will be paid a dividend of $0.13 per share on Friday, June 22nd. This represents a $0.52 dividend on an annualized basis and a yield of 5.03%. The ex-dividend date is Thursday, June 14th. View Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's Dividend History.

What is the consensus analysts' recommendation for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Who are some of Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's key competitors?

Who are Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's key executives?

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's management team includes the folowing people:
  • Mario Joseph Gabelli, Chairman of the Board of Trustees, Chief Investment Officer (Age 75)
  • Agnes Mullady, President, Treasurer (Age 58)
  • Richard J. Walz, Chief Compliance Officer (Age 57)
  • Andrea R. Mango, Vice President, Secretary (Age 44)
  • Carter W. Austin, Vice President (Age 50)
  • Wayne C. Pinsent, Vice President and Ombudsman (Age 30)
  • David I. Schachter, Vice President (Age 63)
  • Adam E. Tokar, Vice President (Age 35)
  • James P. Conn, Lead Independent Trustee (Age 79)
  • Vincent D. Enright, Independent Director (Age 73)

Has Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund been receiving favorable news coverage?

Media stories about GRX stock have trended somewhat positive recently, according to Accern. The research firm identifies negative and positive press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund earned a news sentiment score of 0.07 on Accern's scale. They also gave press coverage about the investment management company an impact score of 45.33 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

Who are Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's major shareholders?

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Matisse Capital (0.47%), Financial & Investment Management Group Ltd. (0.19%) and Cornerstone Wealth Management LLC (0.04%). Company insiders that own Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund stock include Jeffrey J Jonas Jr and Kuni Nakamura. View Institutional Ownership Trends for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund.

Which major investors are selling Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund stock?

GRX stock was sold by a variety of institutional investors in the last quarter, including Matisse Capital. View Insider Buying and Selling for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund.

Which major investors are buying Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund stock?

GRX stock was acquired by a variety of institutional investors in the last quarter, including Financial & Investment Management Group Ltd. and Cornerstone Wealth Management LLC. Company insiders that have bought Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund stock in the last two years include Jeffrey J Jonas Jr and Kuni Nakamura. View Insider Buying and Selling for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund.

How do I buy shares of Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund?

Shares of GRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's stock price today?

One share of GRX stock can currently be purchased for approximately $10.33.

How big of a company is Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund?

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund has a market capitalization of $199.78 million.


MarketBeat Community Rating for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund (NYSE GRX)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  54 (Vote Outperform)
Underperform Votes:  43 (Vote Underperform)
Total Votes:  97
MarketBeat's community ratings are surveys of what our community members think about Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund and other stocks. Vote "Outperform" if you believe GRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.